KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Acquisitions (2021)

Twist Bioscience (TWST) has disclosed Acquisitions for 1 consecutive years, with $8.2 million as the latest value for Q4 2021.

  • Quarterly Acquisitions changed N/A to $8.2 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Sep 2022, changed N/A year-over-year, with the annual reading at $8.2 million for FY2022, 1589.44% up from the prior year.
  • Acquisitions for Q4 2021 was $8.2 million at Twist Bioscience, up from $483000.0 in the prior quarter.
  • The five-year high for Acquisitions was $8.2 million in Q4 2021, with the low at $483000.0 in Q2 2021.